ATE506340T1 - 12-aryl-prostaglandin-analoga - Google Patents
12-aryl-prostaglandin-analogaInfo
- Publication number
- ATE506340T1 ATE506340T1 AT07761718T AT07761718T ATE506340T1 AT E506340 T1 ATE506340 T1 AT E506340T1 AT 07761718 T AT07761718 T AT 07761718T AT 07761718 T AT07761718 T AT 07761718T AT E506340 T1 ATE506340 T1 AT E506340T1
- Authority
- AT
- Austria
- Prior art keywords
- aryl
- prostaglandin analogue
- disclosed
- prostaglandin
- analogue
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
- C07C59/56—Unsaturated compounds containing hydroxy or O-metal groups containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
- C07C65/17—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D333/40—Thiophene-2-carboxylic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74627506P | 2006-05-03 | 2006-05-03 | |
| US74638606P | 2006-05-04 | 2006-05-04 | |
| US11/742,987 US7439372B2 (en) | 2006-05-03 | 2007-05-01 | Therapeutic compounds |
| PCT/US2007/067985 WO2007131012A1 (en) | 2006-05-03 | 2007-05-02 | 12-aryl or heteroaryl prostaglandin analogs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE506340T1 true ATE506340T1 (de) | 2011-05-15 |
Family
ID=38474466
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07761718T ATE506340T1 (de) | 2006-05-03 | 2007-05-02 | 12-aryl-prostaglandin-analoga |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7439372B2 (de) |
| EP (1) | EP2027082B1 (de) |
| JP (1) | JP5247680B2 (de) |
| AT (1) | ATE506340T1 (de) |
| AU (1) | AU2007248119B2 (de) |
| BR (1) | BRPI0711159A2 (de) |
| CA (1) | CA2651022C (de) |
| DE (1) | DE602007014036D1 (de) |
| WO (1) | WO2007131012A1 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7799336B2 (en) | 2004-04-30 | 2010-09-21 | Allergan, Inc. | Hypotensive lipid-containing biodegradable intraocular implants and related methods |
| US20090016981A1 (en) | 2006-05-03 | 2009-01-15 | Allergan, Inc. | Therapeutic compounds |
| AU2007272683B2 (en) | 2006-07-10 | 2012-08-23 | Allergan, Inc. | Substituted cyclopentane derivatives as therapeutic agents |
| NZ585517A (en) * | 2007-11-09 | 2012-08-31 | Allergan Inc | 5-[3-(2-Alkyl-cyclopentyl)-propyl]thiophene-2-carboxylic acid derivatives as prostaglandin analogues, and pharmaceutical uses thereof |
| ES2425769T5 (es) † | 2007-12-20 | 2017-07-28 | University Of Southern California | Aparato para la administración de agentes terapéuticos |
| US8198318B2 (en) * | 2008-03-18 | 2012-06-12 | Allergen, Inc. | Therapeutic amides |
| BRPI0910741A2 (pt) | 2008-04-24 | 2015-09-29 | Allergan Inc | arilciclopentenos substituídos como agonistas de prostaglantina ep2 |
| WO2009132087A1 (en) | 2008-04-24 | 2009-10-29 | Allergan, Inc. | Thiophene derivatives useful as ocular hypotensive agents |
| WO2009131977A1 (en) | 2008-04-24 | 2009-10-29 | Allergan, Inc. | Therapeutic compounds |
| MX2013001227A (es) * | 2010-07-30 | 2013-04-24 | Allergan Inc | Compuestos y metodos para reparacion de piel. |
| US20120142684A1 (en) * | 2010-12-02 | 2012-06-07 | Allergan, Inc. | Compounds and methods for skin repair |
| US9000032B2 (en) | 2013-05-31 | 2015-04-07 | Allergan, Inc. | Substituted cyclopentenes as therapeutic agents |
| RU2650614C2 (ru) | 2013-10-31 | 2018-04-16 | Аллерган, Инк. | Внутриглазные имплантаты, содержащие простамид, и способы их применения |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
| US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
| US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
| ATE194335T1 (de) * | 1993-12-20 | 2000-07-15 | Fujisawa Pharmaceutical Co | 4,5-diaryloxazol-derivate |
| US5462968A (en) | 1994-01-19 | 1995-10-31 | Allergan, Inc. | EP2 -receptor agonists as agents for lowering intraocular pressure |
| ES2171742T3 (es) | 1995-11-14 | 2002-09-16 | Toray Industries | Agente reductor de la presion ocular. |
| US6437146B1 (en) | 1998-09-25 | 2002-08-20 | Fujisawa Pharmaceutical Co., Ltd. | Oxazole compounds as prostaglandin e2 agonists or antagonists |
| PE20020444A1 (es) | 2000-09-22 | 2002-06-14 | Merck & Co Inc | Antagonistas de receptores de taquiquinina zwitterionica |
| NZ532519A (en) | 2001-11-05 | 2006-11-30 | Allergan Inc | Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists |
| US7235586B2 (en) * | 2003-09-09 | 2007-06-26 | Allergan, Inc. | Cyclopentane heptan(ene)oic acid, 2-thiocarbamoyloxy and 2-carbamoyloxy compounds as therapeutic agents |
-
2007
- 2007-05-01 US US11/742,987 patent/US7439372B2/en active Active
- 2007-05-02 AT AT07761718T patent/ATE506340T1/de not_active IP Right Cessation
- 2007-05-02 AU AU2007248119A patent/AU2007248119B2/en not_active Ceased
- 2007-05-02 CA CA2651022A patent/CA2651022C/en not_active Expired - Fee Related
- 2007-05-02 EP EP07761718A patent/EP2027082B1/de not_active Not-in-force
- 2007-05-02 WO PCT/US2007/067985 patent/WO2007131012A1/en active Application Filing
- 2007-05-02 BR BRPI0711159-2A patent/BRPI0711159A2/pt not_active IP Right Cessation
- 2007-05-02 JP JP2009510043A patent/JP5247680B2/ja not_active Expired - Fee Related
- 2007-05-02 DE DE602007014036T patent/DE602007014036D1/de active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US7439372B2 (en) | 2008-10-21 |
| DE602007014036D1 (de) | 2011-06-01 |
| EP2027082B1 (de) | 2011-04-20 |
| AU2007248119A1 (en) | 2007-11-15 |
| BRPI0711159A2 (pt) | 2011-08-23 |
| AU2007248119B2 (en) | 2012-07-05 |
| CA2651022A1 (en) | 2007-11-15 |
| CA2651022C (en) | 2014-08-19 |
| JP5247680B2 (ja) | 2013-07-24 |
| US20070259947A1 (en) | 2007-11-08 |
| EP2027082A1 (de) | 2009-02-25 |
| WO2007131012A9 (en) | 2009-01-08 |
| WO2007131012A1 (en) | 2007-11-15 |
| JP2009535426A (ja) | 2009-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE506340T1 (de) | 12-aryl-prostaglandin-analoga | |
| BRPI0716643A2 (pt) | amidas terapêuticas e compostos relacionados | |
| CY2014030I1 (el) | Θεραπευτικες συνθεσεις που περιλαμβανουν ingenol-3-angelate | |
| EA200802008A1 (ru) | Фармацевтические композиции | |
| NO20064041L (no) | Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter | |
| NO20091395L (no) | Nye tiofenderivater | |
| RS52874B (en) | THYOPHEN ANALYSIS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS | |
| MX2007015424A (es) | Formulaciones ungueales topicas. | |
| EA201070786A1 (ru) | Бензофуропиримидиноны | |
| EA201170703A1 (ru) | Производные адамантилбензамида | |
| EA201070519A1 (ru) | Соединения тропана | |
| DK3072507T3 (da) | Farmaceutiske sammensætninger til glukokortikoidsubstitutionsterapi | |
| TN2011000172A1 (en) | Therapeutic antiviral peptides | |
| MY151973A (en) | Cyclic depsipeptides | |
| WO2008008718A3 (en) | Cyclopentane derivatives as antiglaucoma agents | |
| DK2018158T3 (da) | Ny racecadotril administrationsform | |
| DE502006005053D1 (de) | Spritzbare akustikmassen | |
| CR11423A (es) | NUEVOS INHIBIDORES DE sEH Y SU USO | |
| MX2009001578A (es) | Lactamas terapeuticas. | |
| DK1814848T3 (da) | 2,3,4-substitueret-cyclopentanoner som terapeutiske midler | |
| MX2010004487A (es) | Derivados lactamicos sustituidos y sus usos para glaucoma e hipertension ocular. | |
| UA97369C2 (ru) | Противоопухолевые соединения дигидропиран-2-она и фармацевтическая композиция на их основе | |
| WO2008008700A3 (en) | Substituted cyclopentane derivatives as therapeutic agents | |
| NO20084543L (no) | Benzimidazolderivater | |
| NO20063293L (no) | Farmasoytiske forbindelser |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |